文献速递主动脉外科

无并发症B型主动脉夹层药物治疗失败预测因素

Predictors of Failure of Medical Management in Uncomplicated Type B Aortic Dissection.
PubMed 文献 · Ann Thorac Surg · 2018-10-04

该回顾性研究纳入314例接受最佳药物治疗的无并发症B型主动脉夹层患者,分析影像学与临床特征对治疗失败(需主动脉干预)和死亡的预测价值。中位随访5.6年期间44.9%患者治疗失败需干预,估计失败发生率为46%。多因素分析显示糖尿病、肾衰竭、DeBakey 3B型夹层及降胸主动脉直径≥4.5 cm是治疗失败的独立预测因素,而假腔状态或内脏血管起源分布不预测失败。

要点

  • 无并发症B型主动脉夹层最佳药物治疗失败率高,约46%。
  • 降胸主动脉直径≥4.5 cm是治疗失败的独立预测因素。
  • 糖尿病、肾衰竭、DeBakey 3B型夹层亦为独立预测因素。

核心结论

  • 无并发症B型主动脉夹层患者接受最佳药物治疗后治疗失败发生率显著。
  • 诊断时降胸主动脉直径≥4.5 cm是药物治疗失败的独立预测因素。

研究设计与样本

  • 回顾性队列研究,纳入Emory大学医学院主动脉数据库2000至2016年314例接受最佳药物治疗的无并发症B型主动脉夹层患者。
  • 采用Cox比例风险模型估计风险比并识别药物治疗失败的预测因素。

主要发现

  • 患者平均年龄58±12岁,67%为男性。
  • 假腔状态:通畅59.4%,部分血栓形成39.8%,完全血栓形成0.8%。
  • 中位随访5.6年(四分位距1.4至8.5年),44.9%患者药物治疗失败并接受干预(开放手术58例,血管内治疗83例)。
  • 估计药物治疗失败发生率为46%。
  • 多因素分析识别糖尿病、肾衰竭、DeBakey 3B型夹层及降胸主动脉直径≥4.5 cm(HR 1.39;95%CI 1.24至1.56;p<0.001)为药物治疗失败的独立预测因素。

临床怎么用

  • 对无并发症B型主动脉夹层接受药物治疗的患者,应评估糖尿病、肾衰竭、DeBakey分型及降胸主动脉直径以识别治疗失败高危者。
  • 降胸主动脉直径≥4.5 cm的患者药物治疗失败风险较高,需密切监测并考虑早期干预策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Optimal medical therapy (OMT) for uncomplicated type B aortic dissection (uTBAD) provides excellent short-term outcomes but is associated with a high incidence of failure. This study identified predictors of aortic intervention and mortality in uTBAD patients undergoing OMT. METHODS: A retrospective review of the Emory University School of Medicine aortic database identified 314 uTBAD patients undergoing OMT from 2000 to 2016. Two hundred sixty-three (84%) patients had imaging at presentation analyzed for maximum aortic diameters (ADs), false lumen (FL) status, and visceral vessel perfusion. Cox proportional hazards models were constructed to estimate hazards ratios (HRs) and identify predictors of OMT failure. RESULTS: The mean age of patients was 58 ± 12 years, and 67% were men. FL status was patent in 59.4%, partially thrombosed in 39.8%, and completely thrombosed in 0.8% of patients. Over a median follow-up of 5.6 (interquartile range, 1.4 to 8.5) years, 44.9% of patients failed OMT and underwent intervention (n = 58 open, n = 83 endovascular). The estimated incidence of OMT failure was 46%. Multivariate analysis identified the presence of diabetes, renal failure, DeBakey 3B dissection, and a descending thoracic AD of 4.5 cm or greater (HR, 1.39; 95% confidence interval, 1.24 to 1.56; p < 0.001) to be independent predictors of failure of OMT. FL status or the distribution of visceral vessels arising from the FL did not predict OMT failure. CONCLUSIONS: There is a significant incidence of OMT failure in uTBAD patients. A descending thoracic AD of 4.5 cm or greater at the time of diagnosis is an independent predictor of failure of OMT.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Lou X, Duwayri YM, Chen EP, et al. Predictors of Failure of Medical Management in Uncomplicated Type B Aortic Dissection. Ann Thorac Surg. 2018. PMID: 30292842. doi:10.1016/j.athoracsur.2018.08.012

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。